Rodent Models of Amyotrophic Lateral Sclerosis

Current Protocols in Pharmacology
Thomas Philips, Jeffrey D Rothstein

Abstract

Amyotrophic Lateral Sclerosis (ALS) is a motor neuron disease affecting upper and lower motor neurons in the central nervous system. Patients with ALS develop extensive muscle wasting and atrophy leading to paralysis and death 3 to 5 years after disease onset. The condition may be familial (fALS 10%) or sporadic ALS (sALS, 90%). The large majority of fALS cases are due to genetic mutations in the Superoxide dismutase 1 gene (SOD1, 15% of fALS) and repeat nucleotide expansions in the gene encoding C9ORF72 (∼ 40% to 50% of fALS and ∼ 10% of sALS). Studies suggest that ALS is mediated through aberrant protein homeostasis (i.e., ER stress and autophagy) and/or changes in RNA processing (as in all non-SOD1-mediated ALS). In all of these cases, animal models suggest that the disorder is mediated non-cell autonomously, i.e., not only motor neurons are involved, but glial cells including microglia, astrocytes, and oligodendrocytes, and other neuronal subpopulations are also implicated in the pathogenesis. Provided in this unit is a review of ALS rodent models, including discussion of their relative advantages and disadvantages. Emphasis is placed on correlating the model phenotype with the human condition and the utility of the model f...Continue Reading

References

May 28, 1992·The New England Journal of Medicine·J D RothsteinR W Kuncl
Jun 15, 1994·Journal of Neuroscience Research·D NagyP D Kushner
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·M E RippsJ W Gordon
Mar 1, 1995·The Journal of Cell Biology·K L TanejaR H Singer
Mar 3, 1994·The New England Journal of Medicine·G BensimonV Meininger
Aug 1, 1996·Chemistry & Biology·D R Borchelt, S S Sisodia
Jan 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·David S HowlandJeffrey D Rothstein
Jun 13, 2002·Neuroreport·Ludo Van Den BoschWim Robberecht
Sep 25, 2002·Neurobiology of Disease·Jasna KrizJean-Pierre Julien
May 15, 2003·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·Sanjay KalraDouglas L Arnold
Jan 23, 2004·Experimental Neurology·Lindsey R FischerJonathan D Glass
Apr 24, 2004·American Journal of Human Genetics·Ying-Zhang ChenPhillip F Chance
Jul 23, 2005·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·Marcus BeckMarkus Naumann
Jul 27, 2005·Journal of Neuropathology and Experimental Neurology·Philip Van DammeLudo Van Den Bosch
Aug 24, 2005·Neurology·G M RingholzP E Schulz
Apr 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Han-Xiang DengTeepu Siddique
Jun 3, 2006·Science·Séverine BoilléeDon W Cleveland
Jun 28, 2006·Annals of Neurology·Merit E CudkowiczDaniel B Drachman
Oct 4, 2006·Neuron·Séverine BoilléeDon W Cleveland
Oct 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·David R BeersStanley H Appel
Nov 6, 2007·Lancet Neurology·Paul H GordonUNKNOWN Western ALS Study Group
Feb 29, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Dick JaarsmaCasper C Hoogenraad
Mar 1, 2008·Science·Jemeen SreedharanChristopher E Shaw
May 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Koji YamanakaLawrence S B Goldstein
Aug 16, 2008·The European Journal of Neuroscience·Nathan C StamAnthony J Hannan
Sep 20, 2008·PLoS Genetics·Nicola J RutherfordRosa Rademakers
Nov 26, 2008·Neurology·E J SorensonC A Thornton
Feb 28, 2009·Laboratory Animals·A D SorrellsH Markowitz
Oct 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Iga WegorzewskaRobert H Baloh

❮ Previous
Next ❯

Citations

Nov 26, 2015·Frontiers in Cellular Neuroscience·Gianfranco NataleFrancesco Fornai
Mar 10, 2017·Expert Opinion on Investigational Drugs·Ana MartinezCarmen Gil
Apr 6, 2017·Mammalian Genome : Official Journal of the International Mammalian Genome Society·S L Eaton, T M Wishart
Dec 13, 2016·Biochimica Et Biophysica Acta. Molecular Cell Research·Rawan EidMichael T Greenwood
Jan 19, 2018·Biomedicines·Stéphane Mathis, Gwendal Le Masson
Mar 21, 2018·Nature Neuroscience·Matthew A WhiteJemeen Sreedharan
May 5, 2017·Disease Models & Mechanisms·Philip Van DammeLudo Van Den Bosch
Nov 7, 2018·Journal of Neurogenetics·Sean J MillerJeffrey D Rothstein
Feb 28, 2019·Acta Neuropathologica·Peng YinXiao-Jiang Li
Jan 13, 2019·The Journal of Experimental Medicine·David BrennerJochen H Weishaupt
Jan 23, 2020·Journal of Clinical Medicine·Tereza FilipiAnd Miroslava Anderova
Mar 10, 2019·Neurology·Leonard H van den BergUNKNOWN Airlie House ALS Clinical Trials Guidelines Group
Apr 26, 2020·International Journal of Molecular Sciences·Agata Grazia D'AmicoVelia D'Agata
Jul 1, 2020·Neuropathology and Applied Neurobiology·B A AshfordJ R Highley
Jun 23, 2016·Human Molecular Genetics·Kelsey C PattersonMichelle L Olsen
Jul 16, 2017·Journal of Neurology, Neurosurgery, and Psychiatry·Andrew EisenMatthew C Kiernan
Jan 7, 2017·Acta Neuropathologica·Rachel H TanGlenda M Halliday
Jan 10, 2017·Frontiers in Aging Neuroscience·Julio A AlfieriLionel M Igaz
Sep 13, 2017·Antioxidants & Redox Signaling·Nadia D'AmbrosiMaria Teresa Carrì
Feb 24, 2018·International Journal of Molecular Sciences·Abhirami K IyerChandler L Walker
Oct 17, 2018·Neural Regeneration Research·Jessica R MorriceChristopher A Shaw
Aug 10, 2019·International Journal of Molecular Sciences·Baris GencP Hande Ozdinler
Feb 23, 2020·Journal of Neuropathology and Experimental Neurology·David A DavisDeborah C Mash
Sep 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Chunxing YangZuoshang Xu
Sep 25, 2017·Inflammation·Agnese GugliandoloEmanuela Mazzon
Aug 10, 2017·Frontiers in Aging Neuroscience·Maria Concetta GelosoNadia D'Ambrosi
Oct 5, 2018·Acta Neuropathologica·Elaheh Ekhtiari BidhendiThomas Brännström
Apr 9, 2019·Stem Cells International·Agnese GugliandoloEmanuela Mazzon
Oct 1, 2020·Cell Death and Differentiation·Sara DominguezBaris Bingol
Apr 3, 2016·Wiley Interdisciplinary Reviews. RNA·Kyota Yasuda, Stavroula Mili
Mar 4, 2018·Scientific Reports·M SzelechowskiR Rossignol

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Researcher Network:CZI Neurodegeneration Challenge

The Neurodegeneration Challenge Network aims to provide funding for and to bring together researchers studying neurodegenerative diseases. Find the latest research from the NDCN grantees here.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.